MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/97.5/0.1/21.03.25 Stock MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/97.5/0.1/21.03.25
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/97.5/0.1/21.03.25 Stock

Warrant

DE000MG39KK3

Market Closed - Börse Stuttgart 14:18:31 2024-06-14 EDT
0.167 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/97.5/0.1/21.03.25
Current month+28.46%
1 month+45.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart ASTRAZENECA PLC
Chart MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/97.5/0.1/21.03.25

Latest news about ASTRAZENECA PLC

Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology PR
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy PR
Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research PR
Baili Announces Clinical Trial Collaboration to Evaluate SI-B001, an EGFR x HER3 bispecific Antibody, in Combination with Tagrisso® in Patients with Non-Small Cell Lung Cancer PR
More news

Quotes 5-day view

Date Price Change
24-06-14 0.167 0.00%
24-06-13 0.167 -4.02%
24-06-12 0.174 +10.13%
24-06-11 0.158 -7.60%
24-06-10 0.171 +4.27%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 02:18 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MG39KK
ISINDE000MG39KK3
Date issued 2024-04-30
Strike 97.5 $
Maturity 2025-03-21 (278 Days)
Parity 10 : 1
Emission price 0.14 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.176 €
Lowest since issue 0.092 €
Delta0.21x
Omega 9.233
Premium24.81x
Gearing43.35x
Moneyness 0.8163
Difference Strike 17.91 $
Difference Strike %+18.37%
Spread 0.003 €
Spread %1.73%
Theoretical value 0.1715
Implied Volatility 23.83 %
Total Loss Probability 83.84 %
Intrinsic value 0.000000
Present value 0.1715
Break even 99.34 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
158.6 USD
Average target price
174.4 USD
Spread / Average Target
+9.95%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant